At PRA Health Sciences, we work side-by-side with our clients, to move drug discovery forward, and to help them develop life-saving and life- improving drugs. For more than 30 years, we’ve been helping to bring to market everything from niche treatments and therapies to blockbuster drugs. Providing comprehensive Phase I-IV biopharmaceutical drug development in over 80 countries, we are dedicated to being innovative, and to delivering unmatched scientific expertise that improves the drug development process.
We help change people’s lives for the better every single day. It’s what we are passionate about.
Investor Resources
You may also be interested in:
White Paper
Alzheimer's Disease Research 2018
PRA conducted a survey at the 2018 Alzheimer's Association International Conference in Chicago. Across the board we found that the research community…
page
Clinical Diagnostics
We work with our sponsors to run diagnostic studies in a way that optimizes efficiency and ensures a positive and rewarding study experience for…
White Paper
Cross-Border Enrollment of Rare Disease Patients
Clinical trials in rare diseases present unique challenges unseen in trials for more common conditions. Cross-border enrollment can be key to…